| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 188.05 | 8.6% |
| Total Income | 195.10 | 9.1% |
| Expenditure | 142.89 | 9.6% |
| PBT | 52.21 | 10.2% |
| Net Profit | 38.59 | 10.7% |
| OPM | 39.10% | 0.06pp |
| NPM | 19.78% | 0.28pp |
| EPS | 3.76 | 11.2% |
Vijaya Diagnostic Centre Announces Q1 FY26 Results with 20.4% YoY Revenue Growth
28 Jul 2025 · 28 Jul 2025, 01:57 pm
Summary
Vijaya Diagnostic Centre Limited, one of India’s leading integrated diagnostic chains, has announced its financial results for the quarter ended 30 June 2025, showing a consolidated revenue from operations of 735.3 Rs. Mn, a 20.4% YoY growth.
Key Highlights
- 1
Q1 FY26 Revenue from Operations: 735.3 Rs. Mn (20.4% YoY growth)
- 2
EBITDA: 6.8% QoQ growth, 39.1% EBITDA Margin
- 3
Profit after Tax (PAT): 10.7% QoQ growth, 20.4% PAT Margin
- 4
Total Tests: 3.94 millions (16.7% YoY growth)
- 5
Total Footfall: 1.10 millions (14.4% YoY growth)
- 6
Wellness share: 14.2%
- 7
Average realization per test: 477 Rs.
- 8
Average realization per footfall: 1,707 Rs.
Management Comments
Ms. Suprita Reddy
MD & CEO
Vijaya reported another strong financial quarter, achieving a YOY growth of 20.4%, with our Hyderabad market’s contribution returning to double-digit growth this quarter. The strong performance was largely driven by volume and change in the test mix. I'm happy to state that all the new hubs in Pune, Bengaluru, and West Bengal are up and running, with steady footfall. We remain optimistic about achieving break-even across all centres within the 12 months with 1 hub centre in Bengaluru on track to reach break-even earlier than the estimated timeline. I’m also pleased to share that our Nizamabad hub centre has achieved break-even within 2 quarters of its full-fledged operations. Looking ahead, we would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal. The other 2 hubs in West Bengal are also on track to be operationalized in 2nd half of FY26.”
Informational and educational content only. Not investment advice.